NEW YORK, NY / ACCESSWIRE / March 11, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: CD International Enterprises Inc. (CDII), Solos Endoscopy Inc. (SNDY), Orbital Tracking Corp. (TRKK) and Akzo Nobel NV (AKZOY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
CDII Research Package: http://www.traders-choice.com/pdf?s=CDII
SNDY Research Package: http://www.traders-choice.com/pdf?s=SNDY
TRKK Research Package: http://www.traders-choice.com/pdf?s=TRKK
AKZOY Research Package: http://www.traders-choice.com/pdf?s=AKZOY
Highlights from today's reports include:
On Thursday, March 10, 2016, NASDAQ Composite ended at 4,662.16, down 0.26%, Dow Jones Industrial Average declined 0.03%, to finish the day at 16,995.13, and the S&P 500 closed at 1,989.57, up 0.02%.
- CD International Enterprises Inc.'s stock edged lower by 3.33% to close Thursday's session at USD 0.0029. The company's shares oscillated between USD 0.0027 and USD 0.0031. The stock recorded a trading volume of 16.42 million shares, which was below its 50-day daily average volume of 22.61 million shares but above its 52-week average volume of 14.15 million shares. Over the last three days CD International Enterprises Inc.'s shares have advanced 3.57% and in the past one week the stock has moved insignificantly, remaining flat over the period. In addition, over the last three months the stock has lost 45.28% and in the past six months the shares have shed 88.11%. The stock is trading at a price to book ratio of 0.07. Additionally, the stock is trading at a price to sales ratio of 0.04. The stock has a negative beta of 1.20.
- The stock of Solos Endoscopy Inc. gained 5.71% to close Thursday's session at USD 0.074. The shares of the company moved in the range of USD 0.069 and USD 0.078. A trading volume of 0.80 million shares was recorded, which was above its 52-week average volume of 0.09 million shares. Over the last five days Solos Endoscopy Inc.'s shares have advanced 15.62% while in the past one month the stock has lost 17.78%. In addition, year to date the stock has gained 492%. The stock of Solos Endoscopy Inc. has a price to book ratio of 0.01 and a price to sales ratio of 0.06. The stock is trading above its 50-day moving average of USD 0.05 and below its 200-day moving average of USD 0.12.
- Orbital Tracking Corp.'s stock decreased by 10.00% to close Thursday's session at USD 0.45. The company's shares fluctuated in the range of USD 0.43 and USD 0.51. A total of 0.17 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.04 million shares and was also above its 52-week average volume of 0.01 million shares. Over the last three days Orbital Tracking Corp.'s shares have advanced 2.27% while in the past one week the stock has moved down 10.00%. In addition, over the last three months the stock has lost 60.87% and in the past six months the shares have shed 44.44%. The stock of Orbital Tracking Corp. is trading at a price to book ratio of 2.60 and price to sales ratio of 1.84.
- Akzo Nobel NV's stock slipped by 0.68% to close Thursday's session at USD 20.42. The share price vacillated between USD 20.33 and USD 20.85. The stock recorded a trading volume of 0.03 million shares, which was below its 50-day daily average volume of 0.06 million shares and its 52-week average volume of 0.11 million shares. Over the last five days Akzo Nobel NV's shares have advanced 1.44% and in the past one month the stock has gained a momentum of 1.59%. In addition, over the last three months the stock has lost 9.85% and year to date the shares have shed 8.08%. On a compounded total return basis, the company has returned 5.26% in the past one month. Akzo Nobel NV has a current dividend yield of 2.69%. Further, the company is trading at a price to earnings ratio of 20.63, which compares to a historical PE ratio of 15.75.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice